Pfizer Denied New Trial In $200M Neurontin MDL
Pfizer Inc. on Wednesday lost its bid for a new trial in a multidistrict litigation in Massachusetts in which the drug company was ordered to pay $237 million to the Kaiser...To view the full article, register now.
Already a subscriber? Click here to view full article